A61K 40/4233
Colony stimulating factors [csf]
Official title: {Colony stimulating factors [CSF]}
A61K40/4233 (Colony stimulating factors [csf]) appears on 5 US grants and 15 published applications in this corpus.
Search patents in A61K- Granted patents
- 5
- Published applications
- 15
- Assignees
- 13
- Inventors
- 33
- Latest grant
- 23 Jun 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 2 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 2 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for modulating TH-GM cell function23 Jun 2020US 10,690,666 B2National University of Singapore
- Genetically-modified cells and method for producing same16 Jun 2020US 10,683,355 B2Kissei Pharmaceutical Co., Ltd.
- Uses of conjugates of GM-CSF and IL-7 to treat viral infections19 Jun 2018US 9,999,666 B2Children's Healthcare of Atlanta, Inc.
- Conjugates of GM-CSF and IL-7, compositions and methods related thereto28 Jun 2016US 9,375,465 B2Children's Healthcare of Atlanta, Inc.
- Generation and use of dendritic cells29 Jul 2008US 7,405,076 B2Universite Libre de Bruxelles
- Methods of Treating Glioblastoma29 Jan 2026US 2026/0027201 A1Children's Healthcare of Atlanta, Inc.
- Combination therapy for the treatment of cancer comprising a fas axis antagonist and a t-reg cell depleting agent antagonist14 Aug 2025US 2025/0257141 A1Cancer Research Technology Limited
- Gene editing and engineering stem cells for drug delivery30 Jan 2025US 2025/0032611 A1The Brigham and Women S Hospital, Inc.
- Car vector expressing immune regulatory factor and application thereof3 Oct 2024US 2024/0325442 A1West China Hospital, Sichuan University
- Compositions and methods for immunotherapy27 Jun 2024US 2024/0207319 A1Ludwig Institute for Cancer Research
Most cited
By later US patents